The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2024

Filed:

Jan. 29, 2020
Applicant:

Unity Health Toronto, Toronto, CA;

Inventors:

Xiao-Yan Wen, Toronto, CA;

Anju Philip, Richmond Hill, CA;

Claudia Dossantos, Toronto, CA;

John Marshall, Toronto, CA;

Assignee:

Unity Health Toronto, Toronto, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); A61K 31/404 (2006.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); A61K 31/404 (2013.01); A61P 9/00 (2018.01);
Abstract

The present disclosure relates generally to treatment and diagnosis of diseases, disorders or conditions characterized by vascular leakage. More particularly, the present disclosure relates to methods for treating a vascular leakage-associated disease or disorder in a subject; for reducing vascular leakage in a subject; for reducing reactive oxygen species production in a subject; for inducing apoptosis of neutrophils in a subject; and for increasing survival of a subject having a vascular leakage-associated disease or disorder. The methods comprise administering a G9a and/or G9a-like protein (GLP) methyltransferase inhibitor to the subject. The present disclosure further relates to methods for developing a treatment plan for a subject with a vascular leakage-associated disease, disorder or condition, and for identifying a subject as a candidate for treatment of a vascular leakage-associated disease or disorder. The present disclosure relates to use of G9a and/or G9a-like protein (GLP) methyltransferase inhibitor in the treatment of vascular leakage-associated disease, disorder or condition.


Find Patent Forward Citations

Loading…